Jiayi Li, MD
Gastroenterology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Li’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A76039 · Current
Licensed to practise in California · since 2001 · expires 2027-06-30 · China Medical University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$193,830
Medicare paid this office $193,830 for 805 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 299 | $71,683 | $239 |
| Biopsy of large bowel using a flexible endoscope | 278 | $26,060 | $94 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 224 | $18,905 | $82 |
| Return visit (30+ min) | 139 | $17,176 | $114 |
| Short return visit (20+ min) | 177 | $17,116 | $79 |
See all 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 299 | $71,683 | $239 |
| Biopsy of large bowel using a flexible endoscope | 278 | $26,060 | $94 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 224 | $18,905 | $82 |
| Return visit (30+ min) | 139 | $17,176 | $114 |
| Short return visit (20+ min) | 177 | $17,116 | $79 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 53 | $10,853 | $205 |
| New patient visit (45+ min) | 62 | $8,308 | $134 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 34 | $7,007 | $206 |
| Long return visit (40+ min) | 29 | $4,826 | $166 |
| New patient visit (30+ min) | 31 | $2,798 | $90 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 343 | $1,660 | $5 |
| Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | 11 | $1,215 | $110 |
| Measurement of liver stiffness | 11 | $322 | $27 |
| Injection beneath lining of large bowel using a flexible endoscope | 14 | $210 | $15 |
Procedures Medicare counted
| Colonoscopy | 130 | More than 86% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 153 | More than 85% of doctors who do this |
Who their Medicare patients are
805 Original Medicare patients in 2024. Average age 75 · Under 65 2% · 85 and older 8% · Women 56% · Also on Medicaid 10% · Health risk score 0.83. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 60% · Diabetes 22% · Cancer 19% · Coronary heart disease 16% · Chronic kidney disease 16% · Atrial fibrillation 12% · Depression 9% · Heart failure 5% · COPD 5% · Dementia 4% · Stroke 4%.
The office billed $2,026,189, Medicare allowed $240,216 and paid $193,830; for 1,806 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 805 | 1,806 | 75 | 0.83 | $2,026,189 | $193,830 |
| 2023 | 703 | 1,658 | 74 | 0.83 | $1,575,658 | $166,146 |
| 2022 | 666 | 1,615 | 74 | 0.79 | $1,448,166 | $156,428 |
| 2021 | 708 | 1,758 | 74 | 0.82 | $1,569,437 | $175,065 |
| 2020 | 611 | 1,561 | 74 | 0.90 | $1,352,757 | $147,725 |
| 2019 | 754 | 1,892 | 74 | 0.85 | $1,724,770 | $173,078 |
| 2018 | 706 | 1,947 | 73 | 0.85 | $1,614,281 | $167,788 |
| 2017 | 704 | 1,999 | 74 | 0.92 | $1,598,229 | $171,058 |
| 2016 | 644 | 1,218 | 73 | 0.88 | $1,272,198 | $156,343 |
| 2015 | 620 | 1,128 | 73 | 0.90 | $1,143,671 | $165,807 |
| 2014 | 629 | 1,232 | 73 | 0.85 | $1,295,823 | $171,123 |
| 2013 | 594 | 1,105 | 73 | 0.91 | $1,163,997 | $154,096 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 215 | $52,806 | $244 |
| Biopsy of large bowel using a flexible endoscope | 251 | $26,050 | $103 |
| Short return visit (20+ min) | 159 | $17,448 | $83 |
| Return visit (30+ min) | 109 | $14,869 | $119 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 150 | $13,862 | $89 |
| New patient visit (45+ min) | 87 | $12,800 | $147 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 31 | $6,539 | $211 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 29 | $5,910 | $204 |
| Long return visit (40+ min) | 20 | $3,271 | $164 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 432 | $2,181 | $5 |
| New patient visit (30+ min) | 22 | $1,991 | $90 |
| Injection beneath lining of large bowel using a flexible endoscope | 11 | $172 | $16 |
2022: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 183 | $43,034 | $234 |
| Biopsy of large bowel using a flexible endoscope | 221 | $22,494 | $101 |
| Return visit (30+ min) | 144 | $18,552 | $113 |
| Short return visit (20+ min) | 155 | $15,414 | $80 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 63 | $13,081 | $208 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 152 | $12,985 | $85 |
| New patient visit (45+ min) | 80 | $11,812 | $148 |
| Long return visit (40+ min) | 13 | $2,306 | $177 |
| New patient visit (30+ min) | 22 | $2,121 | $96 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 416 | $2,098 | $5 |
| Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | 12 | $1,988 | $166 |
| Injection beneath lining of large bowel using a flexible endoscope | 25 | $375 | $15 |
2021: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 182 | $43,059 | $235 |
| Biopsy of large bowel using a flexible endoscope | 246 | $24,599 | $100 |
| Return visit (30+ min) | 177 | $24,517 | $116 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 163 | $16,169 | $95 |
| New patient visit (45+ min) | 99 | $14,098 | $142 |
| Short return visit (20+ min) | 140 | $13,597 | $82 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 48 | $10,392 | $217 |
| Long return visit (40+ min) | 44 | $7,235 | $164 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 20 | $4,333 | $217 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 439 | $2,272 | $5 |
| New patient visit (30+ min) | 19 | $1,858 | $98 |
| Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | 11 | $1,746 | $145 |
| Injection beneath lining of large bowel using a flexible endoscope | 34 | $679 | $20 |
2020: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 147 | $35,802 | $242 |
| Biopsy of large bowel using a flexible endoscope | 224 | $23,775 | $106 |
| New patient visit (45+ min) | 121 | $17,578 | $145 |
| Return visit (30+ min) | 135 | $16,157 | $95 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 159 | $15,024 | $92 |
| Long return visit (40+ min) | 72 | $9,525 | $132 |
| Short return visit (20+ min) | 93 | $7,125 | $67 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 30 | $6,599 | $220 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 15 | $3,286 | $219 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 371 | $1,945 | $5 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $1,313 | $73 |
| Injection beneath lining of large bowel using a flexible endoscope | 45 | $684 | $15 |
2019: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 195 | $46,085 | $235 |
| Biopsy of large bowel using a flexible endoscope | 311 | $32,307 | $104 |
| Return visit (30+ min) | 181 | $18,882 | $89 |
| New patient visit (45+ min) | 112 | $16,552 | $148 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 181 | $16,531 | $90 |
| Short return visit (20+ min) | 111 | $9,719 | $70 |
| Long return visit (40+ min) | 56 | $7,601 | $133 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 35 | $7,548 | $216 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 22 | $4,748 | $216 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 483 | $2,433 | $5 |
| New patient visit (60+ min) | 11 | $2,141 | $195 |
| New patient visit (30+ min) | 19 | $1,572 | $83 |
| Injection beneath lining of large bowel using a flexible endoscope | 60 | $1,107 | $18 |
2018: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 171 | $39,888 | $233 |
| Biopsy of large bowel using a flexible endoscope | 309 | $31,851 | $103 |
| Return visit (30+ min) | 191 | $23,598 | $92 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 182 | $16,419 | $89 |
| New patient visit (45+ min) | 89 | $12,548 | $141 |
| Long return visit (40+ min) | 73 | $9,615 | $128 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 35 | $7,439 | $213 |
| Short return visit (20+ min) | 78 | $5,450 | $59 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 22 | $4,679 | $213 |
| New patient visit (60+ min) | 13 | $2,345 | $180 |
| Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | 16 | $2,284 | $143 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 470 | $2,231 | $5 |
| New patient visit (30+ min) | 20 | $1,956 | $98 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 90 | $1,056 | $11 |
| Injection beneath lining of large bowel using a flexible endoscope | 41 | $631 | $15 |
2017: 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 171 | $40,003 | $233 |
| Biopsy of large bowel using a flexible endoscope | 308 | $33,843 | $110 |
| Return visit (30+ min) | 155 | $19,895 | $92 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 164 | $14,857 | $89 |
| New patient visit (45+ min) | 94 | $12,884 | $137 |
| Long return visit (40+ min) | 90 | $11,590 | $123 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 40 | $8,379 | $209 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 32 | $6,797 | $212 |
| Short return visit (20+ min) | 82 | $6,019 | $63 |
| New patient visit (60+ min) | 26 | $4,111 | $158 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 437 | $1,781 | $4 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 160 | $1,679 | $10 |
| Injection beneath lining of large bowel using a flexible endoscope | 69 | $1,407 | $20 |
| New patient visit (30+ min) | 12 | $969 | $81 |
2016: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 139 | $33,225 | $237 |
| Biopsy of large bowel using a flexible endoscope | 224 | $27,449 | $123 |
| Return visit (30+ min) | 134 | $16,267 | $95 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 145 | $14,149 | $95 |
| New patient visit (45+ min) | 93 | $13,349 | $144 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 51 | $10,985 | $215 |
| Long return visit (40+ min) | 70 | $8,942 | $128 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 41 | $8,761 | $214 |
| New patient visit (60+ min) | 39 | $6,965 | $179 |
| Short return visit (20+ min) | 95 | $6,677 | $61 |
| New patient visit (30+ min) | 15 | $1,371 | $91 |
| Injection beneath lining of large bowel using a flexible endoscope | 56 | $1,047 | $19 |
2015: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 130 | $36,630 | $280 |
| Biopsy of large bowel using a flexible endoscope | 206 | $33,042 | $160 |
| Return visit (30+ min) | 137 | $15,297 | $96 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 59 | $14,314 | $243 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 127 | $12,350 | $97 |
| New patient visit (45+ min) | 67 | $10,536 | $157 |
| Long return visit (40+ min) | 68 | $9,028 | $127 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 30 | $7,272 | $242 |
| Short return visit (20+ min) | 88 | $7,187 | $66 |
| New patient visit (60+ min) | 25 | $4,862 | $194 |
| New patient visit (30+ min) | 23 | $1,916 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,173 | $98 |
| Injection beneath lining of large bowel using a flexible endoscope | 29 | $785 | $27 |
2014: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 155 | $40,759 | $261 |
| Biopsy of large bowel using a flexible endoscope | 242 | $35,016 | $144 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 79 | $18,786 | $238 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 146 | $13,145 | $89 |
| Return visit (30+ min) | 124 | $12,979 | $90 |
| New patient visit (45+ min) | 81 | $11,101 | $137 |
| Short return visit (20+ min) | 107 | $8,325 | $62 |
| Long return visit (40+ min) | 52 | $6,921 | $124 |
| New patient visit (60+ min) | 28 | $5,089 | $182 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 19 | $4,576 | $241 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $2,126 | $92 |
| New patient visit (30+ min) | 22 | $1,961 | $89 |
| Injection beneath lining of large bowel using a flexible endoscope | 23 | $604 | $26 |
2013: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 128 | $33,102 | $259 |
| Biopsy of large bowel using a flexible endoscope | 215 | $30,333 | $141 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 126 | $14,750 | $116 |
| Return visit (30+ min) | 125 | $13,622 | $92 |
| New patient visit (45+ min) | 85 | $12,095 | $142 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 47 | $11,354 | $242 |
| Long return visit (40+ min) | 51 | $7,029 | $121 |
| Short return visit (20+ min) | 93 | $6,925 | $63 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 27 | $6,394 | $237 |
| New patient visit (60+ min) | 25 | $4,465 | $179 |
| New patient visit (30+ min) | 37 | $3,324 | $90 |
| Injection beneath lining of large bowel using a flexible endoscope | 28 | $1,124 | $40 |
Medicaid work
$171 in 2023
Medicaid paid $171 for 12 billed services this clinician did in 2023, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 12 | $171 |
| 2023 | 12 | 1 | 12 | $171 |
Drugs they prescribed that Part D paid
$416,589
Pharmacies billed $416,589 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,885 generic and fewer than 11 brand-name prescriptions · $416,589 in drug cost · 37 antibiotic prescriptions to 20 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vemlidy | 159 | $258,270 | $1,624 |
| Creon | 42 | $55,617 | $1,324 |
| Zenpep | 16 | $18,579 | $1,161 |
| Sod Sulf-Potass Sulf-Mag Sulf | 181 | $12,425 | $69 |
| Tenofovir Disoproxil | 91 | $7,598 | $83 |
See all 25 drugs
| Vemlidy | 159 | $258,270 | $1,624 |
| Creon | 42 | $55,617 | $1,324 |
| Zenpep | 16 | $18,579 | $1,161 |
| Sod Sulf-Potass Sulf-Mag Sulf | 181 | $12,425 | $69 |
| Tenofovir Disoproxil | 91 | $7,598 | $83 |
| Linzess | 13 | $7,265 | $559 |
| Pantoprazole | 442 | $6,025 | $14 |
| Peg 3350-Electrolyte | 245 | $4,873 | $20 |
| Ursodiol | 46 | $4,836 | $105 |
| Mesalamine | 13 | $4,282 | $329 |
| Entecavir | 46 | $4,252 | $92 |
| Famotidine | 241 | $3,508 | $15 |
| Omeprazole | 285 | $2,627 | $9 |
| Sucralfate | 55 | $2,094 | $38 |
| Dexlansoprazole Dr | 11 | $1,753 | $159 |
| Gavilyte-G | 121 | $1,564 | $13 |
| Esomeprazole Magnesium | 22 | $1,245 | $57 |
| Rabeprazole | 18 | $938 | $52 |
| Gavilyte-C | 49 | $701 | $14 |
| Peg-3350 and Electrolytes | 41 | $568 | $14 |
| Dicyclomine | 18 | $220 | $12 |
| Ondansetron Odt | 11 | $210 | $19 |
| Amitriptyline | 11 | $191 | $17 |
| Prednisone | 11 | $123 | $11 |
| Ondansetron | 11 | $93 | $8 |
Year by year
| 2024 | 2,349 | 977 | None | None | $416,589 |
| 2023 | 2,013 | 783 | None | None | $453,538 |
| 2022 | 1,967 | 747 | None | 31% | $513,676 |
| 2021 | 2,009 | 732 | None | 33% | $548,801 |
| 2020 | 1,702 | 604 | None | None | $634,205 |
| 2019 | 1,750 | 655 | None | 28% | $567,602 |
| 2018 | 1,746 | 631 | None | 30% | $395,354 |
| 2017 | 1,548 | 561 | 1% (13) | 30% | $454,044 |
| 2016 | 1,550 | 525 | None | 28% | $326,475 |
| 2015 | 1,297 | 442 | None | 30% | $699,753 |
| 2014 | 1,257 | 424 | 1% (11) | 35% | $834,753 |
| 2013 | 993 | 291 | None | None | $171,977 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Vemlidy | 158 | $257,937 | $1,633 |
| Creon | 51 | $84,211 | $1,651 |
| Zenpep | 15 | $15,493 | $1,033 |
| Sod Sulf-Potass Sulf-Mag Sulf | 178 | $14,107 | $79 |
| Entecavir | 70 | $12,286 | $176 |
| Mesalamine | 18 | $11,017 | $612 |
| Pantoprazole | 413 | $7,324 | $18 |
| Ursodiol | 29 | $6,213 | $214 |
| Famotidine | 230 | $5,119 | $22 |
| Peg 3350-Electrolyte | 220 | $4,941 | $22 |
| Tenofovir Disoproxil | 51 | $4,874 | $96 |
| Omeprazole | 311 | $4,286 | $14 |
| Clenpiq | 17 | $3,134 | $184 |
| Dexlansoprazole Dr | 11 | $2,430 | $221 |
| Esomeprazole Magnesium | 13 | $1,516 | $117 |
| Rabeprazole | 19 | $552 | $29 |
| Dicyclomine | 23 | $509 | $22 |
| Ondansetron | 17 | $337 | $20 |
| Amitriptyline | 11 | $273 | $25 |
| Prednisone | 19 | $252 | $13 |
2022: 23 drugs
| Vemlidy | 187 | $286,698 | $1,533 |
| Creon | 78 | $101,515 | $1,301 |
| Mesalamine | 33 | $18,943 | $574 |
| Zenpep | 17 | $18,627 | $1,096 |
| Suprep | 125 | $14,452 | $116 |
| Ursodiol | 32 | $8,973 | $280 |
| Pantoprazole | 359 | $6,811 | $19 |
| Entecavir | 61 | $6,698 | $110 |
| Clenpiq | 28 | $4,750 | $170 |
| Famotidine | 172 | $4,226 | $25 |
| Tenofovir Disoproxil | 38 | $4,078 | $107 |
| Omeprazole | 333 | $3,916 | $12 |
| Dexlansoprazole Dr | 15 | $3,887 | $259 |
| Peg 3350-Electrolyte | 189 | $3,621 | $19 |
| Sucralfate | 17 | $2,810 | $165 |
| Sod Sulf-Potass Sulf-Mag Sulf | 34 | $2,788 | $82 |
| Rabeprazole | 13 | $281 | $22 |
| Dicyclomine | 18 | $228 | $13 |
| Ondansetron | 18 | $206 | $11 |
| Gavilyte-G | 12 | $175 | $15 |
| Amitriptyline | 19 | $139 | $7 |
| Amoxicillin-Clavulanate Potass | 13 | $120 | $9 |
| Prednisone | 14 | $110 | $8 |
2021: 25 drugs
| Vemlidy | 192 | $272,375 | $1,419 |
| Creon | 86 | $118,207 | $1,375 |
| Suprep | 219 | $24,205 | $111 |
| Mesalamine | 33 | $18,431 | $559 |
| Entecavir | 48 | $11,941 | $249 |
| Linzess | 21 | $9,956 | $474 |
| Ursodiol | 30 | $9,126 | $304 |
| Pantoprazole | 350 | $7,935 | $23 |
| Dexilant | 15 | $7,678 | $512 |
| Famotidine | 146 | $5,624 | $39 |
| Clenpiq | 35 | $5,592 | $160 |
| Omeprazole | 429 | $5,422 | $13 |
| Mesalamine Er | 13 | $4,608 | $354 |
| Budesonide Ec | 23 | $2,667 | $116 |
| Tenofovir Disoproxil | 28 | $2,452 | $88 |
| Esomeprazole Magnesium | 15 | $1,089 | $73 |
| Peg3350-Sod Sul-Nacl-Kcl-Asb-C | 11 | $1,030 | $94 |
| Peg 3350-Electrolyte | 39 | $739 | $19 |
| Sucralfate | 11 | $591 | $54 |
| Dicyclomine | 27 | $581 | $22 |
| Lactulose | 11 | $331 | $30 |
| Gavilyte-G | 20 | $269 | $13 |
| Peg-3350 and Electrolytes | 23 | $251 | $11 |
| Gavilyte-C | 15 | $203 | $14 |
| Amitriptyline | 19 | $179 | $9 |
2020: 20 drugs
| Vemlidy | 178 | $257,476 | $1,446 |
| Creon | 57 | $110,684 | $1,942 |
| Mesalamine | 20 | $22,575 | $1,129 |
| Suprep | 126 | $13,209 | $105 |
| Entecavir | 39 | $8,409 | $216 |
| Pantoprazole | 310 | $6,702 | $22 |
| Ursodiol | 11 | $6,450 | $586 |
| Omeprazole | 411 | $5,688 | $14 |
| Dexilant | 14 | $5,680 | $406 |
| Linzess | 12 | $5,259 | $438 |
| Budesonide Ec | 16 | $3,362 | $210 |
| Famotidine | 71 | $2,364 | $33 |
| Tenofovir Disoproxil | 13 | $2,057 | $158 |
| Esomeprazole Magnesium | 22 | $1,085 | $49 |
| Dicyclomine | 47 | $860 | $18 |
| Diphenoxylate-Atropine | 19 | $859 | $45 |
| Peg 3350-Electrolyte | 58 | $833 | $14 |
| Gavilyte-C | 39 | $529 | $14 |
| Gavilyte-N | 32 | $461 | $14 |
| Amitriptyline | 16 | $111 | $7 |
2019: 26 drugs
| Vemlidy | 160 | $207,468 | $1,297 |
| Creon | 70 | $92,124 | $1,316 |
| Mesalamine | 14 | $19,874 | $1,420 |
| Suprep | 128 | $12,803 | $100 |
| Budesonide Ec | 23 | $12,624 | $549 |
| Ursodiol | 11 | $8,127 | $739 |
| Entecavir | 25 | $6,830 | $273 |
| Apriso | 12 | $6,518 | $543 |
| Omeprazole | 415 | $5,300 | $13 |
| Pantoprazole | 288 | $4,569 | $16 |
| Dexilant | 12 | $3,569 | $297 |
| Ranitidine | 134 | $2,193 | $16 |
| Clenpiq | 12 | $1,876 | $156 |
| Esomeprazole Magnesium | 15 | $1,543 | $103 |
| Tenofovir Disoproxil | 18 | $1,462 | $81 |
| Moviprep | 13 | $1,397 | $107 |
| Diphenoxylate-Atropine | 22 | $899 | $41 |
| Famotidine | 27 | $795 | $29 |
| Gavilyte-C | 67 | $767 | $11 |
| Peg 3350-Electrolyte | 39 | $718 | $18 |
| Clarithromycin | 11 | $521 | $47 |
| Gavilyte-N | 29 | $488 | $17 |
| Dicyclomine | 34 | $361 | $11 |
| Peg 3350-Electrolyte | 33 | $305 | $9 |
| Amoxicillin | 12 | $108 | $9 |
| Amitriptyline | 12 | $101 | $8 |
2018: 23 drugs
| Vemlidy | 153 | $184,899 | $1,208 |
| Creon | 63 | $79,683 | $1,265 |
| Entecavir | 46 | $18,901 | $411 |
| Suprep | 189 | $17,785 | $94 |
| Viread | 11 | $13,247 | $1,204 |
| Ursodiol | 15 | $12,721 | $848 |
| Budesonide Ec | 24 | $12,531 | $522 |
| Omeprazole | 391 | $4,467 | $11 |
| Dexilant | 12 | $3,475 | $290 |
| Pantoprazole | 282 | $3,300 | $12 |
| Ranitidine | 135 | $2,307 | $17 |
| Peg 3350-Electrolyte | 91 | $1,601 | $18 |
| Diphenoxylate-Atropine | 26 | $1,586 | $61 |
| Esomeprazole Magnesium | 11 | $900 | $82 |
| Gavilyte-N | 53 | $800 | $15 |
| Clarithromycin | 13 | $603 | $46 |
| Nitroglycerin | 19 | $373 | $20 |
| Lactulose | 16 | $364 | $23 |
| Paroxetine | 13 | $268 | $21 |
| Prednisone | 16 | $203 | $13 |
| Dicyclomine | 19 | $173 | $9 |
| Amoxicillin | 14 | $146 | $10 |
| Amitriptyline | 17 | $135 | $8 |
2017: 17 drugs
| Viread | 67 | $83,000 | $1,239 |
| Vemlidy | 47 | $51,896 | $1,104 |
| Entecavir | 33 | $23,141 | $701 |
| Creon | 38 | $17,455 | $459 |
| Suprep | 123 | $10,878 | $88 |
| Dexilant | 13 | $4,936 | $380 |
| Omeprazole | 434 | $3,709 | $9 |
| Pantoprazole | 234 | $3,009 | $13 |
| Ranitidine | 113 | $1,809 | $16 |
| Peg 3350-Electrolyte | 118 | $1,751 | $15 |
| Diphenoxylate-Atropine | 21 | $906 | $43 |
| Gavilyte-N | 46 | $798 | $17 |
| Prednisone | 18 | $439 | $24 |
| Spironolactone | 12 | $156 | $13 |
| Dicyclomine | 20 | $113 | $6 |
| Amitriptyline | 12 | $110 | $9 |
| Paroxetine | 11 | $55 | $5 |
2016: 22 drugs
| Viread | 95 | $109,751 | $1,155 |
| Entecavir | 33 | $31,634 | $959 |
| Creon | 40 | $13,550 | $339 |
| Nexium | 32 | $13,338 | $417 |
| Ursodiol | 14 | $11,993 | $857 |
| Dexilant | 13 | $5,649 | $435 |
| Omeprazole | 460 | $4,463 | $10 |
| Carafate | 11 | $2,827 | $257 |
| Peg 3350-Electrolyte | 168 | $2,660 | $16 |
| Ranitidine | 102 | $2,459 | $24 |
| Pantoprazole | 174 | $2,155 | $12 |
| Suprep | 20 | $1,654 | $83 |
| Gavilyte-N | 83 | $1,375 | $17 |
| Moviprep | 11 | $954 | $87 |
| Clarithromycin | 15 | $746 | $50 |
| Diphenoxylate-Atropine | 20 | $723 | $36 |
| Prednisone | 15 | $384 | $26 |
| Amitriptyline | 28 | $252 | $9 |
| Propranolol | 11 | $185 | $17 |
| Amoxicillin | 14 | $137 | $10 |
| Paroxetine | 13 | $118 | $9 |
| Metoclopramide | 14 | $49 | $3 |
2015: 20 drugs
| Harvoni | 16 | $508,675 | $31,792 |
| Viread | 55 | $72,255 | $1,314 |
| Nexium | 42 | $16,474 | $392 |
| Entecavir | 12 | $16,378 | $1,365 |
| Creon | 37 | $14,079 | $381 |
| Ursodiol | 21 | $13,849 | $659 |
| Dexilant | 16 | $6,845 | $428 |
| Omeprazole | 376 | $3,827 | $10 |
| Carafate | 12 | $3,384 | $282 |
| Peg 3350-Electrolyte | 121 | $2,067 | $17 |
| Pantoprazole | 177 | $1,941 | $11 |
| Suprep | 18 | $1,450 | $81 |
| Ranitidine | 99 | $1,390 | $14 |
| Moviprep | 15 | $1,205 | $80 |
| Gavilyte-N | 48 | $922 | $19 |
| Diphenoxylate-Atropine | 22 | $658 | $30 |
| Sucralfate | 13 | $478 | $37 |
| Famotidine | 11 | $123 | $11 |
| Metoclopramide | 12 | $111 | $9 |
| Paroxetine | 12 | $91 | $8 |
2014: 18 drugs
| Sovaldi | 12 | $336,284 | $28,024 |
| Viread | 35 | $45,334 | $1,295 |
| Nexium | 59 | $27,894 | $473 |
| Baraclude | 13 | $19,774 | $1,521 |
| Creon | 37 | $18,213 | $492 |
| Ursodiol | 33 | $7,589 | $230 |
| Dexilant | 24 | $7,354 | $306 |
| Moviprep | 62 | $4,821 | $78 |
| Omeprazole | 383 | $4,260 | $11 |
| Suprep | 29 | $2,276 | $78 |
| Pantoprazole | 121 | $1,698 | $14 |
| Ribavirin | 12 | $1,519 | $127 |
| Peg-3350 | 84 | $1,445 | $17 |
| Lansoprazole | 15 | $1,328 | $89 |
| Ranitidine | 93 | $1,135 | $12 |
| Gavilyte-N | 31 | $548 | $18 |
| Paroxetine | 12 | $98 | $8 |
| Dicyclomine | 12 | $50 | $4 |
2013: 15 drugs
| Viread | 40 | $42,029 | $1,051 |
| Baraclude | 24 | $36,942 | $1,539 |
| Creon | 47 | $25,137 | $535 |
| Nexium | 53 | $23,918 | $451 |
| Omeprazole | 330 | $5,554 | $17 |
| Dexilant | 20 | $4,040 | $202 |
| Moviprep | 32 | $2,388 | $75 |
| Ursodiol | 21 | $1,954 | $93 |
| Ranitidine | 115 | $1,331 | $12 |
| Pantoprazole | 56 | $988 | $18 |
| Peg-3350 With Flavor Packs | 42 | $806 | $19 |
| Sucralfate | 12 | $411 | $34 |
| Gavilyte-N | 13 | $230 | $18 |
| Trilyte With Flavor Packets | 11 | $201 | $18 |
| Dicyclomine | 11 | $40 | $4 |
Money from drug and device companies
$504 in 2025
| 2025 | 2 | 15 | None | $504 |
| 2024 | 4 | 5 | None | $308 |
| 2023 | 1 | 1 | None | $150 |
| 2022 | 1 | 1 | None | $92 |
| 2021 | 1 | 2 | None | $40 |
| 2020 | 1 | 3 | None | $42 |
| 2019 | 2 | 20 | None | $338 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Gilead Sciences | None | $365 | 14 payments
|
| Janssen Biotech | Tremfya | $139 | 1 payment
|
See all 15 published payments
| Gilead Sciences | Meals · 2025-12-05 | None | $22 |
| Gilead Sciences | Meals · 2025-11-14 | None | $23 |
| Gilead Sciences | Meals · 2025-10-31 | None | $26 |
| Janssen Biotech | Meals · 2025-10-23 | Tremfya | $139 |
| Gilead Sciences | Meals · 2025-10-10 | None | $23 |
| Gilead Sciences | Meals · 2025-09-12 | None | $19 |
| Gilead Sciences | Meals · 2025-08-08 | None | $17 |
| Gilead Sciences | Meals · 2025-07-18 | None | $32 |
| Gilead Sciences | Meals · 2025-06-06 | None | $18 |
| Gilead Sciences | Meals · 2025-05-13 | None | $19 |
| Gilead Sciences | Meals · 2025-05-01 | None | $76 |
| Gilead Sciences | Meals · 2025-04-04 | None | $20 |
| Gilead Sciences | Meals · 2025-03-21 | None | $20 |
| Gilead Sciences | Meals · 2025-02-21 | None | $19 |
| Gilead Sciences | Meals · 2025-01-14 | None | $31 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $308
| Lilly USA | Omvoh | $125 | 1 payment
|
| Janssen Biotech | Tremfya | $122 | 1 payment
|
| Genzyme | Dupixent | $41 | 2 payments
|
| Gilead Sciences | None | $20 | 1 payment
|
2023: $150
| E.R. Squibb & Sons L.L.C. | Zeposia | $150 | 1 payment
|
2022: $92
| Gilead Sciences | None | $92 | 1 payment
|
2021: $40
| Gilead Sciences | None | $40 | 2 payments
|
2020: $42
| Gilead Sciences | None | $42 | 3 payments
|
2019: $338
| Gilead Sciences | None | $213 | 19 payments
|
| Pfizer | Xeljanz | $125 | 1 payment
|
Professional record
- NPI
- 1902814346
- Licence
- CA A76039California A76039: Current · expires 2027-06-30
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 2350 W. El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-08-03
- NPI last updated
- 2012-10-08
This is when the NPI record was last certified, not a medical board exam.